Inhibitory effect of novel oral hypoglycemic agent nateglinide (AY4166) on peptide transporters PEPT1 and PEPT2

European Journal of Pharmacology

Volumn 392, Issue 1-2, 2000, Pages 11-17

  Terada, Tomohiro ^a   Sawada, Kyoko ^a   Saito, Hideyuki ^a   Hashimoto, Yukiya ^a   Inui, Ken Ichi ^a  

^a KYOTO UNIVERSITY HOSPITAL   (Japan)

Author keywords

Drug interaction; Hypoglycemic agent; Nateglinide; Noncompetitive inhibition; Peptide transporter

Indexed keywords

ALANINE; CARBON 14; CARRIER PROTEIN; CHLORPROPAMIDE; DIPEPTIDE DERIVATIVE; GLIBENCLAMIDE; GLYCYLSARCOSINE; NATEGLINIDE; ORAL ANTIDIABETIC AGENT; SULFONYLUREA; THREONINE; TOLBUTAMIDE;

AMINO ACID TRANSPORT; ANIMAL CELL; ARTICLE; CELL STRAIN CACO 2; CONCENTRATION RESPONSE; CONTROLLED STUDY; DRUG INHIBITION; DRUG UPTAKE; GENETIC TRANSFECTION; HUMAN; HUMAN CELL; MONOLAYER CULTURE; NONHUMAN; PRIORITY JOURNAL;

ADMINISTRATION, ORAL; ALANINE; ANIMALS; CACO-2 CELLS; CARRIER PROTEINS; CYCLOHEXANES; DIPEPTIDES; HUMANS; HYPOGLYCEMIC AGENTS; KINETICS; PHENYLALANINE; RATS; SYMPORTERS; THREONINE;

EID: 0034708570     PISSN: 00142999     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0014-2999(00)00119-9     Document Type: Article

References (29)

1. Akarawut W., Lin C.J., Smith D.E. Noncompetitive inhibition of glycylsarcosine transport by quinapril in rabbit renal brush border membrane vesicles: effect on high-affinity peptide transporter. J. Pharmacol. Exp. Ther. 287:1998;684-690.
2. Akiyoshi M., Kakei M., Nakazaki M., Tanaka H. A new hypoglycemic agent, A-4166, inhibits ATP-sensitive potassium channels in rat pancreatic β-cells. Am. J. Physiol. 268:1995;E185-E193.
3. Balimane P.V., Tamai I., Guo A., Nakanishi T., Kitada H., Leibach F.H., Tsuji A., Sinko P.J. Direct evidence for peptide transporter (PepT1)-mediated uptake of a nonpeptide prodrug, valacyclovir. Biochem. Biophys. Res. Commun. 250:1998;246-251.
4. Boll M., Markovich D., Weber W.M., Korte H., Daniel H., Murer H. Expression cloning of a cDNA from rabbit small intestine related to proton-coupled transport of peptides, β-lactam antibiotics and ACE-inhibitors. Pfluegers Arch. 429:1994;146-149.
5. Bradford M.M. A rapid and sensitive method for the quantitation of microgram quantities of protein utilizing the principle of protein-dye binding. Anal. Biochem. 72:1976;248-254.
6. + symporter in the renal brush border membrane. J. Biol. Chem. 267:1992;9565-9573.
7. 2+ influx. Endocrinology. 134:1994;1395-1400.
8. Ganapathy M.E., Huang W., Wang H., Ganapathy V., Leibach F.H. Valacyclovir: a substrate for the intestinal and renal peptide transporters PEPT1 and PEPT2. Biochem. Biophys. Res. Commun. 246:1998;470-475.
9. Han H.K., de Vrueh R.L.A., Rhie J.K., Covitz K.M.Y., Smith P.L., Lee C.P., Oh D.M., Sadée W., Amidon G.L. 5′-Amino acid esters of antiviral nucleosides, acyclovir, and AZT are absorbed by the intestinal PEPT1 peptide transporter. Pharm. Res. 15:1998;1154-1159.
10. Hu M., Subramanian P., Mosberg H.I., Amidon G.L. Use of the peptide carrier system to improve the intestinal absorption of L-α-methyldopa: carrier kinetics, intestinal permeabilities, and in vitro hydrolysis of dipeptidyl derivatives of L-α-methyldopa. Pharm. Res. 6:1989;66-70.
11. Ikenoue T., Akiyoshi M., Fujitani S., Okazaki K., Kondo N., Maki T. Hypoglycaemic and insulinotropic effects of a novel oral antidiabetic agent, (-)-N-(trans-4-isopropylcyclohexanecabonyl)-D-phenylalanine (A-4166). Br. J. Pharmacol. 120:1997;137-145.
12. Inui K., Terada T. Dipeptide transporters. Amidon G.L., Sadée W. Membrane Transporters as Drug Targets. 1999;269-288 Kluwer Academic/Plenum, New York, NY.
13. Inui K., Yamamoto M., Saito H. Transepithelial transport of oral cephalosporins by monolayers of intestinal epithelial cell line Caco-2: specific transport systems in apical and basolateral membranes. J. Pharmacol. Exp. Ther. 261:1992;195-201.
14. 0. Am. J. Physiol. 272:1997;G1463-G1472.
15. +/peptide cotransporter. Cloning, functional expression, and chromosomal localization. J. Biol. Chem. 270:1995;6456-6463.
16. Lister N., Sykes A.P., Bailey P.D., Boyd C.A.R., Bronk J.R. Dipeptide transport and hydrolysis in isolated loops of rat small intestine: effect of stereospecificity. J. Physiol. (London). 484:1995;173-182.
17. Pan M., Stevens B.R. Differentiation- and protein kinase C-dependent regulation of alanine transport via system B. J. Biol. Chem. 270:1995;3582-3587.
18. Saito H., Inui K. Dipeptide transporters in apical and basolateral membranes of the human intestinal cell line Caco-2. Am. J. Physiol. 265:1993;G289-G294.
19. +/peptide cotransporter mediating absorption of β-lactam antibiotics in the intestine and kidney. J. Pharmacol. Exp. Ther. 275:1995;1631-1637.
20. Saito H., Terada T., Okuda M., Sasaki S., Inui K. Molecular cloning and tissue distribution of rat peptide transporter PEPT2. Biochim. Biophys. Acta. 1280:1996;173-177.
21. Sato Y., Nishikawa M., Shinkai H., Sukegawa E. Possibility of ideal blood glucose control by a new oral hypoglycemic agent, N-[(trans-4-isopropylcyclohexyl)-carbonyl]-D-phenylalanine (A-4166), and its stimulatory effect on insulin secretion in animals. Diabetes Res. Clin. Pract. 12:1991;53-59.
22. Sawada K., Terada T., Saito H., Hashimoto Y., Inui K. Effects of glibenclamide on glycylsarcosine transport by the rat peptide transporters PEPT1 and PEPT2. Br. J. Pharmacol. 128:1999;1159-1164.
23. Sawada K., Terada T., Saito H., Hashimoto Y., Inui K. Recognition of L-amino acid ester compounds by rat peptide transporters PEPT1 and PEPT2. J. Pharmacol. Exp. Ther. 291:1999;705-709.
24. Shinkai H., Nishikawa M., Sato Y., Toi K., Kumashiro I., Seto Y., Fukuma M., Dan K., Toyoshima S. N-(cyclohexylcarbonyl)-D-phenylalanines and related compounds. A new class of oral hypoglycemic agents. 2. J. Med. Chem. 32:1989;1436-1441.
25. Shinkai H., Toi K., Kumashiro I., Seto Y., Fukuma M., Dan K., Toyoshima S. N-acylphenylalanines and related compounds. a new class of oral hypoglycemic agents. J. Med. Chem. 31:1988;2092-2097.
26. +/peptide cotransporters. PEPT1 and PEPT2. J. Biol. Chem. 273:1998;5582-5585.
27. +/peptide cotransporter PEPT1: localization of PEPT1 and transport of β-lactam antibiotics. J. Pharmacol. Exp. Ther. 281:1997;1415-1421.
28. Terada T., Saito H., Mukai M., Inui K. Recognition of β-lactam antibiotics by rat peptide transporters, PEPT1 and PEPT2, in LLC-PK1 cells. Am. J. Physiol. 273:1997;F706-F711.
29. Tsuji A., Tamai I., Nakanishi M., Amidon G.L. Mechanism of absorption of the dipeptide α-methyldopa-phe in intestinal brush-border membrane vesicles. Pharm. Res. 7:1990;308-309.